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Abstract 
Objective 
Sepsis generates significant global acute illness burden. The international variations in 
sepsis epidemiology (illness burden) have implications for region specific health policy. 
We hypothesised that there have been changes over time in the sepsis definitional 
elements (infection and organ dysfunction) and these may have impacted on hospital 
mortality.   
Design: 
Cohort study 
Setting and patients 
To address the proposed hypothesis, we evaluated a high quality, nationally 
representative, clinical, intensive care unit (ICU) database of 967,532 consecutive 
admissions to 181 adult ICUs in England, from January 2000 to December 2012, to 
identify sepsis cases in a robust and reproducible way. Multinomial logistic regression 
was used to report unadjusted trends in sepsis definitional elements and in mortality risk 
categories based on organ dysfunction combinations. We generated logistic regression 
models and assessed statistical interactions with acute hospital mortality as outcome 
and cohort characteristics, sepsis definitional elements and mortality risk categories as 
covariates. Finally, we calculated post-estimation statistics to illustrate the magnitude of 
clinically meaningful improvements in sepsis outcomes over the study period. 
Interventions 
None 
Measurements and Main Results 
Over the study period, there were 248,864 (25.7%) sepsis admissions. Sepsis mortality 
varied by infection sources (19.1% for genitourinary to 43.0% for respiratory; p<0.001), 
by number of organ dysfunctions (18.5% for one to 69.9% for five; p<0.001) and organ 
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 4 
dysfunction combinations (18.5% for risk category 1 to 58.0% for risk category 4). The 
rate of improvement in adjusted hospital mortality was significant (odds ratio 0.939 
[0.934–0.945] per-year; p<0.001), but showed different secular trends in improvement 
between infection sources. 
Conclusions 
Within a sepsis cohort, we illustrate case-mix heterogeneity using definitional elements 
(infection source, organ dysfunction). In the context of improving outcomes, we illustrate 
differential secular trends in impact of these variables on adjusted mortality and propose 
this as a valid reason for international variations in sepsis epidemiology. Our paper 
highlights the need to determine standardized reporting elements for optimal 
comparisons of international sepsis epidemiology. 
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Introduction 
Sepsis is a syndrome defined by life-threatening organ dysfunction due to a dysregulated 
host response to infection(1). Understanding the true global illness burden generated by 
sepsis has important implications for both policy and practice (2-4) – as substantial 
resources are directed towards campaigns to enhance recognition and improve 
management and outcomes, nationally and internationally. This knowledge might inform 
region specific health policy. 
 
Considerable international variation in incidence of (6.0% to 27.0%) and mortality from 
(as high as 80.0%) sepsis has been reported across ICU cohorts(3-6), with recent 
trended data indicating a decrease in mortality.(7-9) However, interpretation of these 
data is challenging as it is likely that differences in the timing and trajectories of pre- and 
within hospital care, enhanced recognition (through campaigns such as the Surviving 
Sepsis Campaign(10) and the Sepsis Six in the UK(11)) and available ICU resources 
(the provision and use of ICU beds), will influence the characteristics of the sepsis 
population admitted to ICU. (3, 12-16) Currently, no international consensus exists for 
standardised reporting of the characteristics of and outcomes for a sepsis population. 
 
Using a nationally representative, clinical, ICU database to identify sepsis cases in a 
robust and reproducible way using physiological and diagnostic data within the first 24 
hours of admission, we set out to describe sepsis case mix (by source of infection and by 
number and combination of systemic inflammatory response syndrome [SIRS] criteria 
and of organ dysfunctions), its impact on mortality, and to illustrate the potential role that 
differences in sepsis case mix might play in the interpretation of ICU epidemiology – all 
with a view to initiating a dialogue for more standardised reporting. 
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Materials and Methods 
Data source 
The Case Mix Programme is the national clinical audit for adult general ICUs in England.  
For consecutive admissions, trained data collectors collect sociodemographic, 
comorbidity and physiological data to precise rules and definitions, during the first 24 
hours following admission to ICU, and outcomes.  Diagnostic data are determined 
clinically and coded using the hierarchical ICNARC Coding Method (additional 
information provided in S-Methods-1).(17) Collected data undergo extensive local and 
central validation prior to pooling into the Case Mix Programme Database (CMPD).(18) 
Support for the collection and use of these data has been obtained under Section 251 of 
the National Health Service (NHS) Act 2006 (approval number PIAG 2–10(f)/2005). 
 
Case selection and definitions 
Using contemporaneous physiological data, definitions for each of the four systemic 
inflammatory response syndrome (SIRS) criteria and each of five organ dysfunctions 
were applied and deemed to be met/not met.  A sepsis admission was defined as any 
admission clinically coded as infection and at least one organ dysfunction (additional 
information provided in S-Methods-1).  
 
Analysis 
The annual number and proportion of sepsis admissions, between January 2000 and 
December 2012, were calculated from the CMPD.  The primary outcome was hospital 
mortality. Population incidence for severe sepsis admissions in England was estimated 
using extrapolation.  Actual numbers for participating ICUs were extrapolated to the total 
number of ICUs in England for each year.  Extrapolated numbers were converted to 
population incidences by dividing by mid-year population estimates obtained from the 
Office for National Statistics (ONS).(19) 
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For each year, cohort characteristics were described by age, sex, presence of severe co-
morbidities, source of admission/surgical urgency, cardiopulmonary resuscitation (CPR) 
within 24 hours prior to admission and illness severity (APACHEII and ICNARC 
physiology scores). For each year, sepsis specific case mix was described by source of 
infection, by the number and combination of SIRS criteria and by number, type and 
combination of organ dysfunctions. Based on the report by Padkin et al (20) 
(Supplementary Appendix, S-Table1), we generated four mortality risk categories to 
illustrate the relationship between number(s) of and type(s) of organ dysfunction 
combinations and associated unadjusted hospital mortality.  After summarizing study 
cohort characteristics, we reported the change over time in proportion of sepsis 
admissions, unadjusted hospital mortality and univariate analyses to show the 
heterogeneity and the associations between definitional elements and unadjusted 
hospital mortality. Multinomial logistic regression was used to report unadjusted trends 
for source of infection, number of SIRS criteria, number of organ dysfunctions and risk 
categories.  
 
Risk-adjusted trends in hospital mortality were evaluated using a logistic regression 
model adjusted for cohort characteristics and sepsis specific case-mix characteristics. To 
assess the presence of interactions between source of infection, organ dysfunctions and 
longitudinal trends, three further logistic regression models were created with interaction 
terms and adjusted for case-mix characteristics. In the first model, the interaction 
between sources of infection over time on risk-adjusted mortality was assessed. The 
second model assessed the interaction between organ dysfunctions (by risk category) 
over time on risk-adjusted mortality. The third model (Model-3) assessed the interaction 
between both source of infection and organ dysfunctions (by risk category) over time on 
risk-adjusted mortality and was also used to generate all the adjusted odds ratios (OR) 
reported. Finally, we assessed whether, if the case mix characteristics had remained the 
same as in 2000 but all characteristic-specific improvements in mortality had occurred as 
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they did, the sepsis mortality by infection source and risk category had truly improved 
over time. Post-estimation predictive margins were used to estimate the marginal 
predicted mortality for each year for sources of infection and risk categories using 
regression Model-3, holding all other covariates at the values observed in 2000. All 
logistic regression models excluded readmissions of the same patient during the same 
hospital stay, were fitted with robust standard errors to account for clustering by ICU, and 
were reported as OR with 95% confidence intervals (CI).  
 
Sensitivity analyses were performed to check the robustness of the findings for the the 
62 ICUs contributing data over the complete study period. Reported p values are two 
sided and p<0.05 was considered to represent a statistically significant result. 
Continuous data were summarized as mean and standard deviation (SD), where 
normally distributed, and median and interquartile range (IQR), where not.  Categorical 
data were presented as frequency and percentage. Admissions with unmeasured 
physiology were assumed not to have met the sepsis case definition. Data completeness 
exceeded 98% in all fields used for case selection, thus complete case analyses were 
used.  All analyses were performed using Stata/SE Version 13.0 (StataCorp LP, College 
Station, TX, USA). 
 
Results 
Over the study period, 248,864 of the 967,532 admissions to adult general ICUs in 
England met the sepsis case definition. The proportion and numbers of sepsis 
admissions increased form 23.5% in 2000 to 25.2% in 2012 (Table-1; sFigure-1). Age 
and sex of sepsis admissions remained relatively stable. The proportion of sepsis 
admissions with severe co-morbidities increased from 16.1% to 19.2% and non-surgical 
admissions formed the majority (from 68.2% in 2000 to 72.9% in 2012). There was a 
decrease in APACHE II and ICNARC Physiology Scores (S-Table-2). The unadjusted 
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 9 
hospital mortality for sepsis admissions decreased from 45.5% in 2000 to 32.1% in 2012 
(Table-1).  
Source of infection and unadjusted mortality 
For sepsis admissions, the source of infection changed significantly over time (test for 
homogeneity, p<0.001). Respiratory tract was the most common source of infection, 
increasing from 40.1% in 2000 to 45.1% in 2012.  Relative to admissions with respiratory 
infections, there was a significant increase in the proportions of admissions with 
genitourinary and musculoskeletal/dermatological infections and a significant reduction in 
the proportions with gastrointestinal, neurological and unknown source infections (all 
p<0.001 for change over time; Figure 1A; S-Table3).  Unadjusted hospital mortality 
varied by source of infection from 19.1% (95% CI 18.2–20.0%) for genitourinary to 
43.0% (95% CI 42.7–43.4%) for respiratory (Figure 1B). 
 
SIRS criteria and unadjusted mortality 
The number of SIRS criteria met amongst sepsis admissions changed significantly over 
time (test for homogeneity, p<0.001). The proportion meeting all 4 SIRS criteria 
decreased from 45.4% in 2000 to 38.4% in 2012. Relative to admissions meeting all 4 
SIRS criteria, there was a significant increase in the proportions of admissions with 0, 1, 
2 or 3 SIRS criteria (all p<0.001 for change over time; Figure 1C; S-Table3).  Unadjusted 
hospital mortality varied by number of SIRS criteria, from 24.7% (95% CI 21.7–28.1%) 
for 0 SIRS to 41.2% (95% CI 40.9–41.6%) for 4 SIRS (Figure 1D). 
 
Number of organ dysfunctions and unadjusted mortality 
The number of organ dysfunctions amongst sepsis admissions changed significantly 
over time (test for homogeneity. p<0.0001). Sepsis admissions with 2 organ dysfunctions 
increased from 28.2% in 2000 to 31.0% in 2012. Relative to admissions with 2 organ 
dysfunctions, there was a significant increase in the proportions of admissions with one 
organ dysfunction and a decrease in admissions with 3, 4 or 5 dysfunctions (all p<0.001 
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for change over time; Figure 1E; S-Table3).  Unadjusted hospital mortality varied by 
number of organ dysfunctions from 18.5% (95% CI 18.1–18.9%) for 1 organ dysfunction 
to 69.9% (95% CI 69.1–70.8%) for 5 organ dysfunctions (Figure 1F).  
 
Illustration of organ dysfunction number and combinations trends using risk category and 
relationship to unadjusted mortality 
Overall hospital mortality by different combinations of number(s) and type(s) of SIRS 
criteria and of organ dysfunctions was variable (Figure 2A and 2B).  
The risk category distribution amongst sepsis admissions changed significantly over time 
(p<0.0001). Risk categories 2 and 3 each constituted one quarter of the cohort, every 
year over the study period and were stable. Between 2000 and 2012, the proportion of 
sepsis admissions categorized as risk category 1 increased from 18.4% to 21.9% while 
those categorized as risk category 4 decreased from 31.0% to 27.3%. Relative to 
admissions in risk category 2, the changes in risk categories 1 and 4 were statistically 
significant (both p<0.001 for change over time), whilst for risk category 3 it was not 
(p=0.47). As anticipated, unadjusted hospital mortality increased across risk categories 
from 18.5% (95% CI 18.1–18.9%) to 58.0% (95% CI 57.7–58.4%) (Figure 2C and 2D; S-
Table3).  
 
Adjusted trends in hospital mortality by infection and organ dysfunction 
The adjusted trend for improvement in hospital mortality for sepsis admissions was 
significant (OR 0.939 [95% CI 0.934–0.945] per year; p<0.001). Adjusted hospital 
mortality decreased significantly within each category of infection source and the rate of 
change over time varied significantly by infection source (respiratory, OR for risk 
category 1, 0.947 [95% CI 0.938–0.956] per year; cardiovascular, 0.937 [0.918–0.957] 
per year; gastrointestinal, 0.941 [0.933–0.950] per year; genitourinary, 0.938 [0.918–
0.959] per year; musculoskeletal/dermatological, 0.943 [0.925–0.962] per year; 
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neurological, 0.939 [0.919–0.960] per year; unknown, 0.919 [0.907–0.932]; all individual 
trends and test of homogeneity p<0.001).  
Adjusted hospital mortality also decreased significantly within each risk category but the 
rate of change was consistent across the risk categories (risk category 1, OR for 
respiratory source 0.947 [95% CI 0.938–0.956] per year; risk category 2, 0.947 [0.939–
0.955] per year; risk category 3, 0.943 [0.935–0.950] per year; risk category 4, 0.947 
[0.940–0.955] per year; all individual trends p<0.001, test of homogeneity p=0.48).  
Finally, the improving trends in hospital mortality appeared truly representative of sepsis 
mortality improvements when the case mix (in terms of all other variables in the model) 
was held constant at the values observed in 2000 (Figure 3 and S-Table 4). 
 
Sensitivity analyses 
Results from the sensitivity analyses (by restricting analyses to the same 62 ICUs 
contributing data over the complete study period), were consistent with the primary 
analyses (S-Table5 and S-Figure-2). 
 
Discussion 
Main findings 
We report an increase in incidence and significant improvements in adjusted hospital 
mortality amongst adult critical care admissions with sepsis in England between 2000 
and 2012. Sepsis admissions represented a heterogeneous population, and a population 
that was changing over time as highlighted by differential trends in definitional elements 
(infection source, SIRS, number and type of organ dysfunctions). The independent 
impact of these definitional elements on mortality was also different. Post-estimation 
predictive margins used to estimate the marginal predicted mortality show clinically 
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relevant improvement in sepsis outcomes between risk categories (such as 12.1% for 
risk category-1; 15.8% for risk category 4) and between infection sources (such as 
13.2% for respiratory infection; 12.3% for urinary infections), despite differences in 
baseline mortality (year 2000) in these sepsis definitional elements. 
Relevance 
Our study introduces the concept that differences in the contribution of each sepsis 
definitional element such as source of infection and type and number of organ 
dysfunctions potentially contributes to the international variation observed across ICU 
cohorts. This concept was implicitly seen when different administrative database 
algorithms were applied(7, 9) but has not been formally tested before. Consistent with 
the published literature, we report an association between sepsis mortality with source of 
infection(21) and with type and number of organ dysfunctions.(22) We also show that, 
within a number of organ dysfunction group, mortality varies by organ dysfunction 
combinations (Figure 2B). 
Illustrative direct comparison 
To further illustrate this issue, we compared the sepsis mortality over from 2000 to 2012 
and the 2012 case-mix characteristics reported by Kaukonen et al for sepsis and septic 
shock admissions from Australia/New Zealand (ANZ).(8) The rationale for this 
comparison includes use of a national ICU database similar to ours over the same time 
period (between 2000 and 2012), the similarities in per capita healthcare spending 
(~US$3,000) and life expectancy at birth (~80 years), albeit there are uncertainties 
around critical care bed provision per 100,000 population (3.5 to 7.4 in United Kingdom 
versus 8.0 to 8.9 in ANZ).(23) Both studies also show similar improvements in adjusted 
hospital mortality for sepsis admissions over time (OR 0.94 per year).  
However, sepsis mortality in our study was 1.5 times higher and mortality curves of the 
two studies are parallel over the entire study period. The mortality comparisons when 
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done using the simple risk categories, the ANZ study mortality is similar to group two 
unadjusted mortality. With case-mix comparisons, as shown by our study, the mortality in 
the ANZ study varies by infection source and other case-mix characteristics, which also 
change with time. In all the case-mix comparisons using 2012 data, the hospital mortality 
in our study was higher than the ANZ study (Figure 4A, Figure 4B, S-Table6). The SIRS 
negative population was much lower in our dataset (3.0% compared to 12.1% reported 
by the ANZ study(24); Figure 4C). These simple illustrative comparisons neither explain 
the reasons for the observed differences in outcomes nor imply that the sepsis outcomes 
are worse in England, but support our study hypothesis of heterogeneity in sepsis case 
mix and the need for standardization of reporting elements to aid direct international 
comparisons. However, this needs to be confirmed using simultaneous direct 
comparison of similar databases using the same criteria to identify sepsis cases. 
Strengths 
The strengths of our study are in the use of a high quality clinical database to identify 
sepsis admissions using accurate, raw physiological data (for SIRS criteria and for organ 
dysfunction variables) and synchronous, clinically coded diagnostic data to identify 
infection for consecutive ICU admissions. Our approach addresses many of the key 
limitations often highlighted in studies of sepsis epidemiology(7, 9, 25-30) namely, 
reliance on administrative/insurance claims data and use of either subjective sepsis 
codes (highly likely influenced by awareness campaigns, influential studies and 
reimbursement formulae) or separate but asynchronous codes for infection and organ 
dysfunction, often coded at discharge. 
Limitations 
There are limitations to our study. First, our database was not primarily designed for ICU 
sepsis epidemiology and therefore the overall incidence of sepsis may be 
underestimated (i.e. some admissions may develop sepsis after the first 24 hours in 
ICU).  However, given the relatively low provision of ICU beds in England (higher 
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threshold for admission)(23, 31) and with 80% of the study cohort having two or more 
organ dysfunctions in the first 24 hours, the impact would likely be minimal. Second, the 
ICUs contributing to the dataset varied over time, which we addressed in our sensitivity 
analyses. Third, the organ dysfunction assessment was cross sectional. Fourth, the 
dataset contains planned and unplanned ICU admissions, where the physiology-modified 
secondary to interventions such as fluid management that would not be similarly 
captured by the organ dysfunction assessment (32) that is a common limitation of large 
database based epidemiology reports.(33) Finally, changes to the health care system 
and increasing awareness of sepsis could have influenced some of the observed 
improvements in outcome(34); however assessment of effects of these changes was not 
the research question addressed by this study. 
Future research 
Definitions are descriptions of illness and criteria provide the variables to identify a 
case(6). To-date, there are neither universally agreed standardized criteria nor reporting 
elements for sepsis epidemiology, which when interpreted with lack of gold-standard 
diagnostic tests for sepsis potentially introduces heterogeneity in epidemiology (6, 35). 
By contrasting our results to similar national database publications (8, 24) over the same 
study period and in the context of a global need for more accurate measurement of 
sepsis(4), our study makes a case for research into directed international sepsis 
epidemiology comparisons using national databases.  Global ecological studies will help 
provide incidence density and identify higher risk areas, which would help design 
regional health policies to tackle sepsis.   
 
Conclusions 
The characteristics of our sepsis ICU population changed over time and so did the 
impact of definitional elements on hospital mortality, which we propose preclude direct 
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international comparisons of incidence and mortality.  We illustrate a case for developing 
an international consensus on standardized reporting of sepsis epidemiology. This has 
important implications, both for health policy and benchmarking.
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Figure Legends 
Figure 1: Sepsis specific case-mix 
Trends in sepsis admissions to adult general intensive care units in England by source of 
infection (panel A) and hospital mortality by source of infection (panel B), by number of 
SIRS criteria (panel C) and hospital mortality by number of SIRS criteria (panel D), 
number of organ dysfunctions (panel E) and hospital mortality by number of organ 
dysfunctions (panel F). The panels A, C and E show the changes over the study period. 
The panels B, D and F show the overall hospital mortality over study period by each 
sepsis definitional element. Abbreviation: No. = Number 
Figure 2: Simple illustration of heterogeneity using number and combinations of 
organ dysfunction (risk categories) and SIRS combinations 
Trends in sepsis admissions to adult general intensive care units in England by SIRS 
combinations (panel A); heterogeneity within number and combinations of organ 
dysfunctions (panel B); risk category (panel C) and hospital mortality by risk category 
(panel D). For description of risk-categories please refer to methods and S-table-1 for 
further details. 
Abbreviations: 
Figure 2A: SIRS = systemic inflammatory response syndrome; T= temperature; H = 
heart rate; R = respiratory rate; W = white cell count 
Figure 2B: R = respiratory; C = cardiovascular; K = renal; H = hematologic; M = 
metabolic 
Figure 3: Post-estimation predictive margins to estimate the marginal predicted 
mortality 
Yearly trends in mortality by infection source (panel A) and by risk category (panel B) 
amongst the sepsis admissions with year 2000 as the referent year are shown. Year 
2000 and 2012 characteristics are shown in S-Table-4. 
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 22 
Figure 4: Comparisons of current study with Kaukonen et al(8) 
Unadjusted sepsis outcomes to adult general intensive care units in England and in 
Australia and New Zealand (panel A); by number and type of organ dysfunction (risk 
category) (panel B) and adjusted sepsis mortality by SIRS positive and negative status 
(panel C). Abbreviations: CMP = Case Mix Programme; SIRS = systemic inflammatory 
response syndrome. 
Table Legend 
Table 1: Numbers of participating adult general intensive care units in England, 
admissions (total and sepsis) and unadjusted mortality   
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Table 1: Numbers of participating adult general intensive care units in England, admissions (total and sepsis) and unadjusted mortality   
Parameters 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Adult general ICUs 
contributing data (n) 101 116 132 143 141 141 141 149 158 162 174 179 181 
Total ICU admissions (n) 35,548 42,261 53,434 62,123 66,294 67,316 67,281 72,820 80,507 85,389 99,688 113,519 121,352 
ICU admissions meeting 
sepsis case definition (n 
(%)) 
8,366 
(23.5) 
9,938 
(23.5) 
12,557 
(23.5) 
15,108 
(24.3) 
16,642 
(25.1) 
17,761 
(26.4) 
18,086 
(26.9) 
19,587 
(26.9) 
21,625 
(26.9) 
23,066 
(27.0) 
26,799 
(26.9) 
28,703 
(25.3) 
30,626 
(25.2) 
Extrapolated ICU 
admissions with sepsis 
18,400 20,100 21,100 23,100 25,000 26,900 27,700 29,700 30,700 31,700 33,400 34,100 36,100 
ICU mortality for severe 
sepsis admissions (n (%)) 
2876 
(34.4) 
3337 
(33.6) 
4154 
(33.1) 
5005 
(33.1) 
5374 
(32.3) 
5445 
(30.7) 
5478 
(30.3) 
5601 
(28.6) 
5968 
(27.6) 
6254 
(27.1) 
7031 
(26.2) 
7093 
(24.7) 
7316 
(23.9) 
Hospital mortality for 
sepsis admissions (n (%)) 
3469 
(45.5) 
3968 
(44.6) 
5053 
(44.1) 
6019 
(44.0) 
6527 
(43.2) 
6780 
(41.6) 
6750 
(40.9) 
7020 
(39.1) 
7446 
(37.3) 
7807 
(36.7) 
8772 
(35.3) 
8797 
(33.2) 
9115 
(32.1) 
 
ICU – Intensive Care Unit 
Table-1
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